BIT
SLNO

BlackRock Institutional Trust’s Soleno Therapeutics SLNO Stock Holding History

BlackRock Institutional Trust’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$61K Hold
1,000
– – ﹤0.01% 3691
2016
Q3 		$68K Hold
1,000
– – ﹤0.01% 3727
2016
Q2 		$87K Hold
1,000
– – ﹤0.01% 3724
2016
Q1 		$89K Hold
1,000
– – ﹤0.01% 3733
2015
Q4 		$139K Hold
1,000
– – ﹤0.01% 3707
2015
Q3 		$158K Buy
+1,000
New +$181K ﹤0.01% 3675

Other funds holding SLNO

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust's SLNO Position: Q4 2016 in Review

BlackRock Institutional Trust held its Soleno Therapeutics (SLNO) position steady in Q4 2016 at 1,000 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #3691.

BlackRock Institutional Trust first reported a position in SLNO in Q3 2015 and has held it in 6 quarters since. The position peaked at $158K in Q3 2015. 12 funds tracked by Wall St. Rank hold SLNO as of Q4 2016.

  • BlackRock Institutional Trust held 1,000 shares of Soleno Therapeutics worth $61K as of Q4 2016.
  • BlackRock Institutional Trust left its Soleno Therapeutics share count unchanged in Q4 2016.
  • Soleno Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3691 holding.
  • BlackRock Institutional Trust first reported a position in Soleno Therapeutics in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Institutional Trust's Soleno Therapeutics position peaked at $158K in Q3 2015.
  • 12 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.